Asgedom, SW and Tesfaye, D and Nirayo, YL and Atey, TM, Time to death and risk factors among tuberculosis patients in Northern Ethiopia, BMC Research Notes, 11 pp. 1-6. ISSN 1756-0500 (2018) [Refereed Article]
|PDF (Published version)|
© The Author(s) 2018. Open Access This article is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) License, (https://creativecommons.org/licenses/by/4.0/) which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
Objective: The main objective of this study was to assess time to death and associated risk factors among tuberculosis (TB) patients.
Results: A total of 769 TB patients were studied and of those, 87 (11.3%) patients died. All of the deaths occurred within 7 months of anti-tuberculosis therapy. Extra-pulmonary TB (AHR = 17.376, 95% CI; 3.88–77.86, p < 0.001) as compared to pulmonary TB and cotrimoxazole prophylaxis therapy (CPT) (AHR = 0.15, 95% CI; 0.03–0.74, p = 0.02) were found to be the predictors of mortality. We noticed higher rates of mortality. Extra-pulmonary TB patients have high risk and TB-HIV co-infected patients who received CPT have low risk of death. Improving early diagnosis of extra-pulmonary TB and early CPT initiation of TB-HIV co-infected patients could minimize patient’s mortality.
|Item Type:||Refereed Article|
|Keywords:||time to death, tuberculosis, risk factors, Ethiopia|
|Research Division:||Biomedical and Clinical Sciences|
|Research Group:||Pharmacology and pharmaceutical sciences|
|Research Field:||Clinical pharmacy and pharmacy practice|
|Objective Group:||Human pharmaceutical products|
|Objective Field:||Human pharmaceutical treatments|
|UTAS Author:||Atey, TM (Mr Tesfay Atey)|
|Downloads:||9 View Download Statistics|
Repository Staff Only: item control page